Article
Next steps in the identification of gene targets for type 1 diabetes.
Diabetologia - 1 Nov 2020
Grant Struan F A, Wells Andrew D, Rich Stephen S
Abstract excerpt
The purpose of this review is to provide a view of the future of genomics and other omics approaches in defining the genetic contribution to all stages of risk of type 1 diabetes and the functional impact and clinical implementations of the associated variants. From the recognition nearly 50 years ago that genetics (in the form of HLA) distinguishes risk of type 1 diabetes from type 2 diabetes, advances in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.